SCHEMBL26435342

SCHEMBL26435342

c1ccc(-c2cc(-c3ccccc3)cc(-c3nc(-c4ccc5c(c4)sc4ccccc45)nc(-c4cccc5ccc6ccccc6c45)n3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 1/20 0.36
ALDH1A1 P00352 4/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
RAB9A P51151 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
MCL1 Q07820 2/20 0.33
ALOX5 P09917 1/20 0.33
KDM4E B2RXH2 3/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ATM Q13315 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25817919 0.93 F9 (0.34) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL26435388 0.93 PIM3 (0.36) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL26435354 0.92 ALDH1A1 (0.36) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL26435367 0.91 F9 (0.38) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL26435343 0.90 F9 (0.36) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL24473201 0.90 F9 (0.36) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL27454715 0.90 F9 (0.36) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL25622522 0.90 F9 (0.36) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL26435378 0.90 PIM3 (0.39) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL26435438 0.90 F9 (0.35) F9ALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 F9 688/4885ALDH1A1 1532/4885MAPT 2425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.